You are currently viewing a new version of our website. To view the old version click .

Clinical Imaging and Newest Therapies for Prostate Cancer

This special issue belongs to the section “Nephrology & Urology“.

Special Issue Information

Dear Colleagues,

Clinical imaging and the latest therapies for prostate cancer have witnessed remarkable advancements, revolutionizing the diagnosis and treatment landscape. State-of-the-art imaging techniques, such as microscopy imaging (multiphoton, confocal, and microultrasound), as well as in vivo imaging techniques, have significantly improved diagnostic accuracy, enabling the detection of early stage prostate cancer and enhancing disease monitoring.

Moreover, novel therapeutic approaches are reshaping prostate cancer treatment. Innovative therapies, including targeted treatments such as PARP inhibitors, are offering promising outcomes and improved survival rates for patients. Additionally, advances in minimally invasive techniques and robotic-assisted surgeries have reduced the invasiveness of treatments and enhanced patient recovery, and focal therapies are finding a new way in with clinical trials using new laser ablation techniques.

In this Special Issue, we invite authors to submit papers on the clinical imaging and newest therapies for prostate cancer.

Dr. Patrick Julien Treacy
Dr. Ruban Thanigasalam
Dr. Scott Leslie
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate
  • cancer
  • multiphoton
  • PSMA
  • MRI
  • lymphadenectomy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383